P450 efficacy and safety of ragweed slit-tablet from a large trial in children with allergic

Ragweed sublingual immunotherapy (SLIT)-tablet improves symptoms and decreases rescue medication use in adults with allergic rhinitis with or without conjunctivitis (AR/C) but has not been evaluated in children. This international, double-blind, placebo-controlled trial evaluated the efficacy and safety of ragweed SLIT-tablet in children with AR/C.

Source: Annals of Allergy, Asthma and Immunology - October 31, 2019 Category: Allergy & Immunology Authors: H. Nolte, D. Bernstein, H. Nelson, A. Ellis, J. Kleine-Tebbe, S. Lu Tags: Rhinitis, Other Upper Airway Disorders Source Type: research